Viewing Study NCT01512758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-02-01 @ 5:27 PM
Study NCT ID: NCT01512758
Status: COMPLETED
Last Update Posted: 2019-03-15
First Post: 2012-01-13
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
None Lymphomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None East Asian Patients View
None Advanced solid tumors View
None Lymphomas View
None MLN8237 View
None Alisertib View
None Aurora A Kinase Inhibitor View
None Drug therapy View